365 related articles for article (PubMed ID: 16502396)
1. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
Sanyal AJ; Banas C; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Heuman D; Coterrell A; Fisher RA; Contos MJ; Mills AS
Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
Hui JM; Kench JG; Chitturi S; Sud A; Farrell GC; Byth K; Hall P; Khan M; George J
Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
[TBL] [Abstract][Full Text] [Related]
3. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
[TBL] [Abstract][Full Text] [Related]
4. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.
Ratziu V; Bonyhay L; Di Martino V; Charlotte F; Cavallaro L; Sayegh-Tainturier MH; Giral P; Grimaldi A; Opolon P; Poynard T
Hepatology; 2002 Jun; 35(6):1485-93. PubMed ID: 12029634
[TBL] [Abstract][Full Text] [Related]
5. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States.
Hu KQ; Tong MJ
Hepatology; 1999 Apr; 29(4):1311-6. PubMed ID: 10094980
[TBL] [Abstract][Full Text] [Related]
6. Long course and prognostic factors of virus-induced cirrhosis of the liver.
Gentilini P; Laffi G; La Villa G; Romanelli RG; Buzzelli G; Casini-Raggi V; Melani L; Mazzanti R; Riccardi D; Pinzani M; Zignego AL
Am J Gastroenterol; 1997 Jan; 92(1):66-72. PubMed ID: 8995940
[TBL] [Abstract][Full Text] [Related]
7. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
Charlton M; Kasparova P; Weston S; Lindor K; Maor-Kendler Y; Wiesner RH; Rosen CB; Batts KP
Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228
[TBL] [Abstract][Full Text] [Related]
8. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
9. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G;
Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811
[TBL] [Abstract][Full Text] [Related]
10. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
Caldwell SH; Oelsner DH; Iezzoni JC; Hespenheide EE; Battle EH; Driscoll CJ
Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
[TBL] [Abstract][Full Text] [Related]
11. Chronic liver disease in diabetes mellitus.
Amarapurkar D; Das HS
Trop Gastroenterol; 2002; 23(1):3-5. PubMed ID: 12170918
[TBL] [Abstract][Full Text] [Related]
12. A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C.
Bonis PA; Tong MJ; Blatt LM; Conrad A; Griffith JL
Am J Gastroenterol; 1999 Jun; 94(6):1605-12. PubMed ID: 10364032
[TBL] [Abstract][Full Text] [Related]
13. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
[TBL] [Abstract][Full Text] [Related]
14. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of cirrhosis caused by hepatitis C].
Bosques Padilla F
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S56-60. PubMed ID: 12712856
[TBL] [Abstract][Full Text] [Related]
16. Subacute liver failure in obese women.
Caldwell SH; Hespenheide EE
Am J Gastroenterol; 2002 Aug; 97(8):2058-62. PubMed ID: 12190177
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein synthesis in nonalcoholic steatohepatitis.
Charlton M; Sreekumar R; Rasmussen D; Lindor K; Nair KS
Hepatology; 2002 Apr; 35(4):898-904. PubMed ID: 11915037
[TBL] [Abstract][Full Text] [Related]
18. [Liver cirrhosis--current aspects of diagnosis and therapy.2: therapy of complications].
Held C
Z Arztl Fortbild (Jena); 1990; 84(16):819-24. PubMed ID: 2171234
[No Abstract] [Full Text] [Related]
19. [Risk factors for development of hepatocellular carcinoma in patients with liver cirrhosis associated with hepatitis C virus].
Matsushita E; Unoura M; Kaneko S; Kobayashi K
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):727-30. PubMed ID: 7563864
[No Abstract] [Full Text] [Related]
20. [High risk group for evolution of hepatocellular carcinoma from HCV related liver cirrhosis].
Hayashi S
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):736-9. PubMed ID: 7563866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
